Market Executive Summary
The global market for Subdermal Contraceptive Implants was estimated to be worth US$ 734 million in 2024 and is forecast to a readjusted size of US$ 1113 million by 2031 with a CAGR of 6.2% during the forecast period 2025-2031.of the upper arm.
Subdermal Contraceptive Implants are a long-term birth control option for women. A subdermal contraceptive implant is a flexible plastic rod about the size of a matchstick that is placed under the skin
Increase in use of modern contraceptive methods, rising awareness about sexual health and family planning, and increase in government initiatives are likely to drive the market during the forecast period.
This report aims to provide a comprehensive presentation of the global market for Subdermal Contraceptive Implants, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Subdermal Contraceptive Implants by region & country, by Type, and by Application.
The Subdermal Contraceptive Implants market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Subdermal Contraceptive Implants.
Global Subdermal Contraceptive Implants Companies Covered
Bayer AG, Merck & Co. Inc., Shanghai Dahua Pharmaceutical Co., Ltd.
Global Subdermal Contraceptive Implants Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Subdermal Contraceptive Implants Market, Segment by Type
Original
Generic
Global Subdermal Contraceptive Implants Market, Segment by Application
Hospital
Clinic
Others
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Subdermal Contraceptive Implants company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Subdermal Contraceptive Implants in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Subdermal Contraceptive Implants in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Related Reports:
Global Artificial Cornea and Corneal Implant Market Size, Share, Growth Drivers, Revenue Analysis and Demand Forecast To 2030
Global Human Microchip Implant Market Size, Share, Growth, Analysis, Trends and Forecast - 2029
Table of Contents
Table of Contents
1 Market Overview
1.1 Subdermal Contraceptive Implants Product Introduction
1.2 Global Subdermal Contraceptive Implants Market Size Forecast (2020-2031)
1.3 Subdermal Contraceptive Implants Market Trends & Drivers
1.3.1 Subdermal Contraceptive Implants Industry Trends
1.3.2 Subdermal Contraceptive Implants Market Drivers & Opportunity
1.3.3 Subdermal Contraceptive Implants Market Challenges
1.3.4 Subdermal Contraceptive Implants Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Subdermal Contraceptive Implants Players Revenue Ranking (2024)
2.2 Global Subdermal Contraceptive Implants Revenue by Company (2020-2025)
2.3 Key Companies Subdermal Contraceptive Implants Manufacturing Base Distribution and Headquarters
2.4 Key Companies Subdermal Contraceptive Implants Product Offered
2.5 Key Companies Time to Begin Mass Production of Subdermal Contraceptive Implants
2.6 Subdermal Contraceptive Implants Market Competitive Analysis
2.6.1 Subdermal Contraceptive Implants Market Concentration Rate (2020-2025)
2.6.2 Global 5 and 10 Largest Companies by Subdermal Contraceptive Implants Revenue in 2024
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Subdermal Contraceptive Implants as of 2024)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Original
3.1.2 Generic
3.2 Global Subdermal Contraceptive Implants Sales Value by Type
3.2.1 Global Subdermal Contraceptive Implants Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Subdermal Contraceptive Implants Sales Value, by Type (2020-2031)
3.2.3 Global Subdermal Contraceptive Implants Sales Value, by Type (%) (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Others
4.2 Global Subdermal Contraceptive Implants Sales Value by Application
4.2.1 Global Subdermal Contraceptive Implants Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Subdermal Contraceptive Implants Sales Value, by Application (2020-2031)
4.2.3 Global Subdermal Contraceptive Implants Sales Value, by Application (%) (2020-2031)
5 Segmentation by Region
5.1 Global Subdermal Contraceptive Implants Sales Value by Region
5.1.1 Global Subdermal Contraceptive Implants Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Subdermal Contraceptive Implants Sales Value by Region (2020-2025)
5.1.3 Global Subdermal Contraceptive Implants Sales Value by Region (2026-2031)
5.1.4 Global Subdermal Contraceptive Implants Sales Value by Region (%), (2020-2031)
5.2 North America
5.2.1 North America Subdermal Contraceptive Implants Sales Value, 2020-2031
5.2.2 North America Subdermal Contraceptive Implants Sales Value by Country (%), 2024 VS 2031
5.3 Europe
5.3.1 Europe Subdermal Contraceptive Implants Sales Value, 2020-2031
5.3.2 Europe Subdermal Contraceptive Implants Sales Value by Country (%), 2024 VS 2031
5.4 Asia Pacific
5.4.1 Asia Pacific Subdermal Contraceptive Implants Sales Value, 2020-2031
5.4.2 Asia Pacific Subdermal Contraceptive Implants Sales Value by Region (%), 2024 VS 2031
5.5 South America
5.5.1 South America Subdermal Contraceptive Implants Sales Value, 2020-2031
5.5.2 South America Subdermal Contraceptive Implants Sales Value by Country (%), 2024 VS 2031
5.6 Middle East & Africa
5.6.1 Middle East & Africa Subdermal Contraceptive Implants Sales Value, 2020-2031
5.6.2 Middle East & Africa Subdermal Contraceptive Implants Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Subdermal Contraceptive Implants Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Subdermal Contraceptive Implants Sales Value, 2020-2031
6.3 United States
6.3.1 United States Subdermal Contraceptive Implants Sales Value, 2020-2031
6.3.2 United States Subdermal Contraceptive Implants Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Subdermal Contraceptive Implants Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Subdermal Contraceptive Implants Sales Value, 2020-2031
6.4.2 Europe Subdermal Contraceptive Implants Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Subdermal Contraceptive Implants Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Subdermal Contraceptive Implants Sales Value, 2020-2031
6.5.2 China Subdermal Contraceptive Implants Sales Value by Type (%), 2024 VS 2031
6.5.3 China Subdermal Contraceptive Implants Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Subdermal Contraceptive Implants Sales Value, 2020-2031
6.6.2 Japan Subdermal Contraceptive Implants Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Subdermal Contraceptive Implants Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Subdermal Contraceptive Implants Sales Value, 2020-2031
6.7.2 South Korea Subdermal Contraceptive Implants Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Subdermal Contraceptive Implants Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Subdermal Contraceptive Implants Sales Value, 2020-2031
6.8.2 Southeast Asia Subdermal Contraceptive Implants Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Subdermal Contraceptive Implants Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Subdermal Contraceptive Implants Sales Value, 2020-2031
6.9.2 India Subdermal Contraceptive Implants Sales Value by Type (%), 2024 VS 2031
6.9.3 India Subdermal Contraceptive Implants Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Bayer AG
7.1.1 Bayer AG Profile
7.1.2 Bayer AG Main Business
7.1.3 Bayer AG Subdermal Contraceptive Implants Products, Services and Solutions
7.1.4 Bayer AG Subdermal Contraceptive Implants Revenue (US$ Million) & (2020-2025)
7.1.5 Bayer AG Recent Developments
7.2 Merck & Co. Inc.
7.2.1 Merck & Co. Inc. Profile
7.2.2 Merck & Co. Inc. Main Business
7.2.3 Merck & Co. Inc. Subdermal Contraceptive Implants Products, Services and Solutions
7.2.4 Merck & Co. Inc. Subdermal Contraceptive Implants Revenue (US$ Million) & (2020-2025)
7.2.5 Merck & Co. Inc. Recent Developments
7.3 Shanghai Dahua Pharmaceutical Co., Ltd.
7.3.1 Shanghai Dahua Pharmaceutical Co., Ltd. Profile
7.3.2 Shanghai Dahua Pharmaceutical Co., Ltd. Main Business
7.3.3 Shanghai Dahua Pharmaceutical Co., Ltd. Subdermal Contraceptive Implants Products, Services and Solutions
7.3.4 Shanghai Dahua Pharmaceutical Co., Ltd. Subdermal Contraceptive Implants Revenue (US$ Million) & (2020-2025)
7.3.5 Shanghai Dahua Pharmaceutical Co., Ltd. Recent Developments
8 Industry Chain Analysis
8.1 Subdermal Contraceptive Implants Industrial Chain
8.2 Subdermal Contraceptive Implants Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Subdermal Contraceptive Implants Sales Model
8.5.2 Sales Channel
8.5.3 Subdermal Contraceptive Implants Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Figures
Table of Figures
List of Tables
Table 1. Subdermal Contraceptive Implants Market Trends
Table 2. Subdermal Contraceptive Implants Market Drivers & Opportunity
Table 3. Subdermal Contraceptive Implants Market Challenges
Table 4. Subdermal Contraceptive Implants Market Restraints
Table 5. Global Subdermal Contraceptive Implants Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Subdermal Contraceptive Implants Revenue Market Share by Company (2020-2025)
Table 7. Key Companies Subdermal Contraceptive Implants Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Subdermal Contraceptive Implants Product Type
Table 9. Key Companies Time to Begin Mass Production of Subdermal Contraceptive Implants
Table 10. Global Subdermal Contraceptive Implants Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Subdermal Contraceptive Implants as of 2024)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Subdermal Contraceptive Implants Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 14. Global Subdermal Contraceptive Implants Sales Value by Type (2020-2025) & (US$ Million)
Table 15. Global Subdermal Contraceptive Implants Sales Value by Type (2026-2031) & (US$ Million)
Table 16. Global Subdermal Contraceptive Implants Sales Market Share in Value by Type (2020-2025)
Table 17. Global Subdermal Contraceptive Implants Sales Market Share in Value by Type (2026-2031)
Table 18. Global Subdermal Contraceptive Implants Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 19. Global Subdermal Contraceptive Implants Sales Value by Application (2020-2025) & (US$ Million)
Table 20. Global Subdermal Contraceptive Implants Sales Value by Application (2026-2031) & (US$ Million)
Table 21. Global Subdermal Contraceptive Implants Sales Market Share in Value by Application (2020-2025)
Table 22. Global Subdermal Contraceptive Implants Sales Market Share in Value by Application (2026-2031)
Table 23. Global Subdermal Contraceptive Implants Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 24. Global Subdermal Contraceptive Implants Sales Value by Region (2020-2025) & (US$ Million)
Table 25. Global Subdermal Contraceptive Implants Sales Value by Region (2026-2031) & (US$ Million)
Table 26. Global Subdermal Contraceptive Implants Sales Value by Region (2020-2025) & (%)
Table 27. Global Subdermal Contraceptive Implants Sales Value by Region (2026-2031) & (%)
Table 28. Key Countries/Regions Subdermal Contraceptive Implants Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 29. Key Countries/Regions Subdermal Contraceptive Implants Sales Value, (2020-2025) & (US$ Million)
Table 30. Key Countries/Regions Subdermal Contraceptive Implants Sales Value, (2026-2031) & (US$ Million)
Table 31. Bayer AG Basic Information List
Table 32. Bayer AG Description and Business Overview
Table 33. Bayer AG Subdermal Contraceptive Implants Products, Services and Solutions
Table 34. Revenue (US$ Million) in Subdermal Contraceptive Implants Business of Bayer AG (2020-2025)
Table 35. Bayer AG Recent Developments
Table 36. Merck & Co. Inc. Basic Information List
Table 37. Merck & Co. Inc. Description and Business Overview
Table 38. Merck & Co. Inc. Subdermal Contraceptive Implants Products, Services and Solutions
Table 39. Revenue (US$ Million) in Subdermal Contraceptive Implants Business of Merck & Co. Inc. (2020-2025)
Table 40. Merck & Co. Inc. Recent Developments
Table 41. Shanghai Dahua Pharmaceutical Co., Ltd. Basic Information List
Table 42. Shanghai Dahua Pharmaceutical Co., Ltd. Description and Business Overview
Table 43. Shanghai Dahua Pharmaceutical Co., Ltd. Subdermal Contraceptive Implants Products, Services and Solutions
Table 44. Revenue (US$ Million) in Subdermal Contraceptive Implants Business of Shanghai Dahua Pharmaceutical Co., Ltd. (2020-2025)
Table 45. Shanghai Dahua Pharmaceutical Co., Ltd. Recent Developments
Table 46. Key Raw Materials Lists
Table 47. Raw Materials Key Suppliers Lists
Table 48. Subdermal Contraceptive Implants Downstream Customers
Table 49. Subdermal Contraceptive Implants Distributors List
Table 50. Research Programs/Design for This Report
Table 51. Key Data Information from Secondary Sources
Table 52. Key Data Information from Primary Sources
Table 53. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Subdermal Contraceptive Implants Product Picture
Figure 2. Global Subdermal Contraceptive Implants Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Subdermal Contraceptive Implants Sales Value (2020-2031) & (US$ Million)
Figure 4. Subdermal Contraceptive Implants Report Years Considered
Figure 5. Global Subdermal Contraceptive Implants Players Revenue Ranking (2024) & (US$ Million)
Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Subdermal Contraceptive Implants Revenue in 2024
Figure 7. Subdermal Contraceptive Implants Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 8. Original Picture
Figure 9. Generic Picture
Figure 10. Global Subdermal Contraceptive Implants Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 11. Global Subdermal Contraceptive Implants Sales Value Market Share by Type, 2024 & 2031
Figure 12. Product Picture of Hospital
Figure 13. Product Picture of Clinic
Figure 14. Product Picture of Others
Figure 15. Global Subdermal Contraceptive Implants Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 16. Global Subdermal Contraceptive Implants Sales Value Market Share by Application, 2024 & 2031
Figure 17. North America Subdermal Contraceptive Implants Sales Value (2020-2031) & (US$ Million)
Figure 18. North America Subdermal Contraceptive Implants Sales Value by Country (%), 2024 VS 2031
Figure 19. Europe Subdermal Contraceptive Implants Sales Value, (2020-2031) & (US$ Million)
Figure 20. Europe Subdermal Contraceptive Implants Sales Value by Country (%), 2024 VS 2031
Figure 21. Asia Pacific Subdermal Contraceptive Implants Sales Value, (2020-2031) & (US$ Million)
Figure 22. Asia Pacific Subdermal Contraceptive Implants Sales Value by Region (%), 2024 VS 2031
Figure 23. South America Subdermal Contraceptive Implants Sales Value, (2020-2031) & (US$ Million)
Figure 24. South America Subdermal Contraceptive Implants Sales Value by Country (%), 2024 VS 2031
Figure 25. Middle East & Africa Subdermal Contraceptive Implants Sales Value, (2020-2031) & (US$ Million)
Figure 26. Middle East & Africa Subdermal Contraceptive Implants Sales Value by Country (%), 2024 VS 2031
Figure 27. Key Countries/Regions Subdermal Contraceptive Implants Sales Value (%), (2020-2031)
Figure 28. United States Subdermal Contraceptive Implants Sales Value, (2020-2031) & (US$ Million)
Figure 29. United States Subdermal Contraceptive Implants Sales Value by Type (%), 2024 VS 2031
Figure 30. United States Subdermal Contraceptive Implants Sales Value by Application (%), 2024 VS 2031
Figure 31. Europe Subdermal Contraceptive Implants Sales Value, (2020-2031) & (US$ Million)
Figure 32. Europe Subdermal Contraceptive Implants Sales Value by Type (%), 2024 VS 2031
Figure 33. Europe Subdermal Contraceptive Implants Sales Value by Application (%), 2024 VS 2031
Figure 34. China Subdermal Contraceptive Implants Sales Value, (2020-2031) & (US$ Million)
Figure 35. China Subdermal Contraceptive Implants Sales Value by Type (%), 2024 VS 2031
Figure 36. China Subdermal Contraceptive Implants Sales Value by Application (%), 2024 VS 2031
Figure 37. Japan Subdermal Contraceptive Implants Sales Value, (2020-2031) & (US$ Million)
Figure 38. Japan Subdermal Contraceptive Implants Sales Value by Type (%), 2024 VS 2031
Figure 39. Japan Subdermal Contraceptive Implants Sales Value by Application (%), 2024 VS 2031
Figure 40. South Korea Subdermal Contraceptive Implants Sales Value, (2020-2031) & (US$ Million)
Figure 41. South Korea Subdermal Contraceptive Implants Sales Value by Type (%), 2024 VS 2031
Figure 42. South Korea Subdermal Contraceptive Implants Sales Value by Application (%), 2024 VS 2031
Figure 43. Southeast Asia Subdermal Contraceptive Implants Sales Value, (2020-2031) & (US$ Million)
Figure 44. Southeast Asia Subdermal Contraceptive Implants Sales Value by Type (%), 2024 VS 2031
Figure 45. Southeast Asia Subdermal Contraceptive Implants Sales Value by Application (%), 2024 VS 2031
Figure 46. India Subdermal Contraceptive Implants Sales Value, (2020-2031) & (US$ Million)
Figure 47. India Subdermal Contraceptive Implants Sales Value by Type (%), 2024 VS 2031
Figure 48. India Subdermal Contraceptive Implants Sales Value by Application (%), 2024 VS 2031
Figure 49. Subdermal Contraceptive Implants Industrial Chain
Figure 50. Subdermal Contraceptive Implants Manufacturing Cost Structure
Figure 51. Channels of Distribution (Direct Sales, and Distribution)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
This report focuses on:
► Intelligent insights to take informed business decisions.
► Qualitative and quantitative analysis of the market.
► Market size and forecasts from 2024 to 2030.
► Opportunities for expansion and in-depth market analysis.
► Segmentation and regional revenue forecasts.
► Analysis of the market share and competitive landscape.
► Strategic recommendations for future growth.
You'll also receive:
► A comprehensive market research report in PDF or PPT formats.
► Access to our analysts to learn more about the report and get answers to your specific business questions.
► The option to customize the report to meet your specific needs, such as adding more countries or regions or developing abusiness case to launch a new product.
Contact us today to learn more and get sample report.
Our Research Reports Look Like This
